ELANNYSEPharmaceutical PreparationsFiscal year ends December 31
Elanco Animal Health Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$23.49−0.06 (-0.25%)
Close on Oct 19, 2026
- Market cap
- $11.88B
- P/E (TTM)
- –
- Dividend yield
- –
Elanco Animal Health Inc revenue by segment
By business segment
By product or service
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pet Health | $718.00M | $710.00M | $489.00M | $533.00M | $643.00M | $635.00M | $439.00M | $486.00M | $579.00M | $639.00M | $416.00M | $495.00M | 52.5% | +11.7% |
| Farm Animal: | $633.00M | $642.00M | $640.00M | $593.00M | $583.00M | $546.00M | $570.00M | $530.00M | $594.00M | $556.00M | $610.00M | $561.00M | 46.3% | +8.6% |
| Cattle | $313.00M | $316.00M | $296.00M | $289.00M | $268.00M | $272.00M | $253.00M | $253.00M | $257.00M | $244.00M | $249.00M | $242.00M | 22.9% | +16.8% |
| Poultry | $223.00M | $230.00M | $237.00M | $217.00M | $215.00M | $189.00M | $213.00M | $188.00M | $198.00M | $197.00M | $220.00M | $184.00M | 16.3% | +3.7% |
| Swine | $97.00M | $96.00M | $107.00M | $87.00M | $100.00M | $85.00M | $104.00M | $88.00M | $90.00M | $84.00M | $98.00M | $93.00M | 7.1% | -3.0% |
| Contract Manufacturing and Other | $17.00M | $19.00M | $15.00M | $11.00M | $15.00M | $12.00M | $11.00M | $14.00M | $11.00M | $10.00M | $9.00M | $12.00M | 1.2% | +13.3% |
| Aqua | – | – | $0 | $0 | $0 | $0 | $0 | $1.00M | $49.00M | $31.00M | $43.00M | $42.00M | – | – |
By region
| Revenue | Q2 26 | Q1 26 | Q4 25 | Q3 25 | Q2 25 | Q1 25 | Q4 24 | Q3 24 | Q2 24 | Q1 24 | Q4 23 | Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| International | $705.00M | $766.00M | $604.00M | $590.00M | $648.00M | $639.00M | $545.00M | $543.00M | $641.00M | $674.00M | $574.00M | $589.00M | 51.5% | +8.8% |
| United States | $663.00M | $605.00M | $540.00M | $547.00M | $593.00M | $554.00M | $475.00M | $487.00M | $543.00M | $531.00M | $461.00M | $479.00M | 48.5% | +11.8% |
From the segment and revenue-disaggregation notes of Elanco Animal Health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.